Stay updated on Elunate® Phase IV Study in Chinese Patients Clinical Trial
Sign up to get notified when there's something new on the Elunate® Phase IV Study in Chinese Patients Clinical Trial page.

Latest updates to the Elunate® Phase IV Study in Chinese Patients Clinical Trial page
- Check5 days agoChange DetectedThe revision label in the ClinicalTrials.gov page footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check12 days agoChange DetectedThe study record for the Phase IV Elunate® (fruquintinib) study has been replaced by a 403 Forbidden error page.SummaryDifference15%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study details. This blocks access to the record and navigation, reflecting a site access issue rather than a data update.SummaryDifference15%

- Check47 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a backend or content management update to the study details page. This appears to be a maintenance update rather than a change to the study content.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page footer now shows Revision: v3.6.5, replacing Revision: v3.6.4, indicating a newer revision of the page content.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page revision stamp was updated from v3.6.3 to v3.6.4, indicating a minor maintenance update to the page.SummaryDifference0.1%

Stay in the know with updates to Elunate® Phase IV Study in Chinese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elunate® Phase IV Study in Chinese Patients Clinical Trial page.